ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 150 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 24.50 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $22,718,000 | +60.2% | 1,204,600 | 0.0% | 2.53% | +81.4% |
| Q2 2019 | $14,178,000 | -18.3% | 1,204,600 | -5.3% | 1.40% | -11.0% |
| Q1 2019 | $17,355,000 | +190.9% | 1,271,500 | +118.5% | 1.57% | +67.2% |
| Q4 2018 | $5,965,000 | -38.4% | 582,030 | 0.0% | 0.94% | +3.1% |
| Q3 2018 | $9,690,000 | +5.4% | 582,030 | 0.0% | 0.91% | +9.9% |
| Q2 2018 | $9,196,000 | – | 582,030 | – | 0.83% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 2,942,203 | $36,042,000 | 9.93% |
| Foresite Capital Management II, LLC | 1,043,832 | $12,787,000 | 5.18% |
| Redmile Group, LLC | 6,476,766 | $79,340,000 | 3.91% |
| DAFNA Capital Management LLC | 346,013 | $4,239,000 | 2.63% |
| Cormorant Asset Management, LP | 900,000 | $11,025,000 | 1.95% |
| SENZAR ASSET MANAGEMENT, LLC | 641,170 | $7,854,000 | 1.92% |
| Asymmetry Capital Management, L.P. | 105,228 | $1,289,000 | 1.50% |
| New Leaf Venture Partners, L.L.C. | 171,364 | $2,099,000 | 0.97% |
| EMERALD ADVISERS, LLC | 1,578,477 | $19,336,000 | 0.79% |
| BB BIOTECH AG | 2,266,008 | $27,759,000 | 0.77% |